INHIBITORS OF TUBULIN POLYMERIZATION

Details for Australian Patent Application No. 2003216322 (hide)

Owner RIGEL PHARMACEUTICALS, INC.

Inventors GOFF, Dane

Pub. Number AU-A-2003216322

PCT Number PCT/US03/05009

PCT Pub. Number WO2003/070241

Priority 60/357,560 15.02.02 US

Filing date 18 February 2003

Wipo publication date 9 September 2003

International Classifications

A61K 031/44 - Non-condensed pyridines

C07D 515/02 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 239/70 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/357,560 15.02.02 US

9 October 2003 Application Open to Public Inspection

  Published as AU-A-2003216322

4 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003216323-Inhibition of vascular endothelial growth factor (vegf) and vegf receptor gene expression using short interfereing nucleic acid (sina)

2003216321-TAMPER-RESISTANT TRANSDERMAL OPIOID DELIVERY DEVICES